Revenue Recognition (Tables)

9 Months Ended

Oct. 02, 2021

Revenue from Contract with Customer [Abstract]

Disaggregation of Revenue

We generated net sales in the following geographic locations(1) (in millions):

	Three Months Ended				Nine Months Ended
	October 2, 2021		September 26, 2020		October 2, 2021		September 26, 2020
U.S.	$	657.4	$	638.7	$	1,859.0	$	1,913.4
Europe(2)	334.5		326.6		1,037.6		1,011.0
All other countries(3)	50.8		37.7		137.2		110.6
Total net sales	$	1,042.7	$	1,003.0	$	3,033.8	$	3,035.0

(1) Derived from the location of the entity that sells to a third party.

(2) Includes Ireland net sales of $7.6 million and $17.4 million for the three and nine months ended October 2, 2021 respectively, and $10.8 million and $22.3 million for the three and nine months ended September 26, 2020, respectively.

(3) Includes net sales generated primarily in Mexico, Australia and Canada.

Product Category

The following is a summary of our net sales by category (in millions):

	Three Months Ended				Nine Months Ended
	October 2, 2021		September 26, 2020		October 2, 2021		September 26, 2020
CSCA(1)
Upper respiratory	$	121.9	$	117.1	$	345.8	$	397.2
Digestive health	110.6		111.8		344.0		339.9
Pain and sleep-aids	108.4		102.6		292.9		325.7
Nutrition	105.3		100.3		293.3		291.5
Oral self-care	76.7		81.9		227.4		202.5
Healthy lifestyle	72.9		86.9		214.9		256.2
Skincare and personal hygiene	56.0		51.4		165.9		145.4
Vitamins, minerals, and supplements	8.1		6.3		24.3		19.1
Other CSCA(2)	34.3		5.7		48.5		14.7
Total CSCA	694.2		664.0		1,957.0		1,992.2
CSCI
Skincare and personal hygiene	88.5		83.1		307.9		275.4
Upper respiratory	58.7		62.3		144.2		191.9
Vitamins, minerals, and supplements	54.7		52.9		162.8		139.9
Pain and sleep-aids	52.1		49.0		148.4		136.0
Healthy lifestyle	42.2		40.6		140.5		124.7
Oral self-care	24.4		25.2		72.4		68.8
Digestive health	10.1		6.8		28.3		17.9
Other CSCI(3)	17.8		19.1		72.3		88.2
Total CSCI	348.5		339.0		1,076.8		1,042.8
Total net sales	$	1,042.7	$	1,003.0	$	3,033.8	$	3,035.0

(1) Includes net sales from our OTC contract manufacturing business.

(2) Consists primarily of diagnostic and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.

(3) Consists primarily of our distribution business and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.

Contract with Customer Balances

The following table provides information about contract assets from contracts with customers (in millions):

	Balance Sheet Location	October 2, 2021		December 31, 2020
Short-term contract assets	Prepaid expenses and other current assets	$	42.2	$	19.7